Feb. 5 (UPI) -- The White House is expected to launch its new prescription drug platform, TrumpRx, on Thursday evening, showcasing the president's new "most favored nation" drug pricing policy.
President Donald Trump initially announced his plan in September with the launch of the TrumpRx website.
The idea is to sell prescription drugs at lower prices via the website, so that people without insurance can pay less. But users have to pay in cash because the site will not accept insurance.
The White House said at the time in a fact sheet, "foreign nations can no longer use price controls to freeride on American innovation by guaranteeing MFN prices on all new innovative medicines Pfizer brings to market."
At the time, Pfizer was the only company on board. Since then, Eli Lilly, Novo Nordisk, Bristol-Myers Squibb, Merck, Amgen, Gilead, GSK, Sanofi, Roche's Genentech, Boehringer Ingelheim, AstraZeneca, EMD Serono and Novartis have joined.
